Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GNS 561

Drug Profile

GNS 561

Alternative Names: GNS-561

Latest Information Update: 17 Jul 2020

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Genoscience
  • Class Antifibrotics; Antineoplastics; Small molecules
  • Mechanism of Action Apoptosis stimulants; Autophagy inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Liver cancer
  • Preclinical Cholangiocarcinoma; Hepatic fibrosis

Most Recent Events

  • 22 Jun 2020 Safety and pharmacodynamics data from preclinical trial in Liver cancer presented at the 111th Annual Meeting of the American Association for Cancer Research - II (AACR-II-2020)
  • 08 Nov 2019 Pharmacodynamics data from the preclinical studies in Hepatic fibrosis presented at the 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2019)
  • 08 Nov 2019 Genoscience Pharma plans a clinical trial for Hepatic fibrosis in
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top